FI921876L - Farmaceutisk komposition innehaollande diritromycin - Google Patents

Farmaceutisk komposition innehaollande diritromycin Download PDF

Info

Publication number
FI921876L
FI921876L FI921876A FI921876A FI921876L FI 921876 L FI921876 L FI 921876L FI 921876 A FI921876 A FI 921876A FI 921876 A FI921876 A FI 921876A FI 921876 L FI921876 L FI 921876L
Authority
FI
Finland
Prior art keywords
diritromycin
farmaceutisk
komposition
innehaollande
komposition innehaollande
Prior art date
Application number
FI921876A
Other languages
English (en)
Finnish (fi)
Other versions
FI921876A7 (fi
FI921876A0 (fi
Inventor
James Michael Greene
Holly Marie Hankins
Gregory Alan Stephenson
David Dale Wirth
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of FI921876A0 publication Critical patent/FI921876A0/fi
Publication of FI921876A7 publication Critical patent/FI921876A7/fi
Publication of FI921876L publication Critical patent/FI921876L/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Formation And Processing Of Food Products (AREA)
FI921876A 1991-04-29 1992-04-27 Farmaceutisk komposition innehaollande diritromycin FI921876L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US69284291A 1991-04-29 1991-04-29

Publications (3)

Publication Number Publication Date
FI921876A0 FI921876A0 (fi) 1992-04-27
FI921876A7 FI921876A7 (fi) 1992-10-30
FI921876L true FI921876L (fi) 1992-10-30

Family

ID=24782254

Family Applications (2)

Application Number Title Priority Date Filing Date
FI921876A FI921876L (fi) 1991-04-29 1992-04-27 Farmaceutisk komposition innehaollande diritromycin
FI921877A FI101795B1 (fi) 1991-04-29 1992-04-27 Menetelmiä diritromysiinin muodon II valmistamiseksi ja eristämiseksi sekä välituotteena käyttökelpoinen kiteinen diritromysiinin solvaatti

Family Applications After (1)

Application Number Title Priority Date Filing Date
FI921877A FI101795B1 (fi) 1991-04-29 1992-04-27 Menetelmiä diritromysiinin muodon II valmistamiseksi ja eristämiseksi sekä välituotteena käyttökelpoinen kiteinen diritromysiinin solvaatti

Country Status (27)

Country Link
EP (2) EP0511799B1 (cs)
JP (2) JP3333545B2 (cs)
KR (2) KR100194307B1 (cs)
CN (2) CN1069197C (cs)
AT (2) ATE138924T1 (cs)
AU (2) AU646734B2 (cs)
BR (2) BR9201540A (cs)
CA (2) CA2067274C (cs)
CY (2) CY1946A (cs)
CZ (2) CZ282218B6 (cs)
DE (2) DE69214710T2 (cs)
DK (2) DK0511799T3 (cs)
ES (2) ES2093779T3 (cs)
FI (2) FI921876L (cs)
GR (2) GR3020439T3 (cs)
HK (2) HK153696A (cs)
HU (2) HU213613B (cs)
IE (2) IE76296B1 (cs)
IL (2) IL101705A (cs)
MX (2) MX9201944A (cs)
MY (2) MY114226A (cs)
NO (2) NO179504C (cs)
NZ (2) NZ242506A (cs)
RU (2) RU2045953C1 (cs)
TW (2) TW216399B (cs)
YU (2) YU44392A (cs)
ZA (2) ZA922776B (cs)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW271400B (cs) * 1992-07-30 1996-03-01 Pfizer
CR5278A (es) * 1995-03-24 1996-07-04 Lilly Co Eli Formulacion oral de 2-metil-tieno-benzodiacepina
ES2173057T3 (es) * 1996-07-29 2004-11-16 Abbott Laboratories Preparacion de la forma ii cristalina de claritromicina.
ID21762A (id) * 1996-09-24 1999-07-22 Lilly Co Eli Formulasi partikel bersaput
RU2147234C1 (ru) * 1999-03-09 2000-04-10 Жемчугов Владислав Евгеньевич Препарат для профилактики и лечения особо опасных инфекционных заболеваний
US6390690B1 (en) 2000-05-17 2002-05-21 3M Innovative Properties Company Fiber optic connector for coupling devices on intersecting planes
RU2212242C1 (ru) * 2001-12-24 2003-09-20 Закрытое акционерное общество "Брынцалов-А" Антибиотик сумазид
KR101120483B1 (ko) * 2006-12-05 2012-02-29 브리스톨-마이어즈 스퀴브 컴페니 모틸라이드 다형체
CN102145008B (zh) * 2010-12-29 2013-06-05 辰欣药业股份有限公司 一种地红霉素药物组合物及其制备方法
CN107151261B (zh) * 2017-06-09 2020-06-12 广州大光制药有限公司 一种地红霉素化合物的晶型及其结晶制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT342770B (de) * 1975-04-07 1978-04-25 Thomae Gmbh Dr K Verfahren zur herstellung neuer erythromycinderivate
DE2515075C2 (de) * 1975-04-07 1985-10-24 Dr. Karl Thomae Gmbh, 7950 Biberach Erythromycinderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
EP0184921A3 (en) * 1984-12-08 1986-10-29 Beecham Group Plc Erythromycin derivatives
DE3524572A1 (de) * 1985-07-10 1987-01-15 Thomae Gmbh Dr K Feste arzneimittelformen zur peroralen anwendung enthaltend 9-deoxo-11-deoxy-9,11-(imino(2-(2-methoxyethoxy)ethyliden)-oxy)-(9s)-erythromycin und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
CA2067275A1 (en) 1992-10-30
CA2067275C (en) 2002-11-26
NO180450C (no) 1997-04-23
DK0511799T3 (da) 1996-06-24
CN1066186A (zh) 1992-11-18
YU44392A (sh) 1994-12-28
HK215096A (en) 1996-12-13
HU215917B (hu) 1999-03-29
CY1946A (en) 1992-04-27
JPH05117289A (ja) 1993-05-14
NO179504C (no) 1996-10-23
HUT62595A (en) 1993-05-28
FI921876A7 (fi) 1992-10-30
IL101705A (en) 1996-01-31
IE921346A1 (en) 1992-11-04
DK0511800T3 (da) 1997-04-21
NO921617L (no) 1992-10-30
IE76296B1 (en) 1997-10-08
FI921877L (fi) 1992-10-30
NO179504B (no) 1996-07-15
HU9203168D0 (en) 1992-12-28
IE74885B1 (en) 1997-08-13
CZ282218B6 (cs) 1997-06-11
HUT63956A (en) 1993-11-29
NO921616D0 (no) 1992-04-27
TW315371B (cs) 1997-09-11
NO921616L (no) 1992-10-30
NO921617D0 (no) 1992-04-27
BR9201541A (pt) 1992-12-01
MY114226A (en) 2002-09-30
CS127792A3 (en) 1992-11-18
RU2045953C1 (ru) 1995-10-20
DE69214710D1 (de) 1996-11-28
AU646734B2 (en) 1994-03-03
EP0511799A1 (en) 1992-11-04
JP3333545B2 (ja) 2002-10-15
MX9201944A (es) 1992-11-01
CN1069197C (zh) 2001-08-08
FI101795B (fi) 1998-08-31
ATE138924T1 (de) 1996-06-15
KR920019364A (ko) 1992-11-19
AU655978B2 (en) 1995-01-19
CA2067274A1 (en) 1992-10-30
EP0511800B1 (en) 1996-10-23
GR3020439T3 (en) 1996-10-31
IL101704A (en) 1998-02-22
YU44492A (sh) 1994-06-24
IL101704A0 (en) 1992-12-30
EP0511799B1 (en) 1996-06-05
IE921345A1 (en) 1992-11-04
CN1030611C (zh) 1996-01-03
DE69214710T2 (de) 1997-03-13
DE69211220T2 (de) 1996-11-07
CA2067274C (en) 2002-10-15
MY109498A (en) 1997-02-28
HK153696A (en) 1996-08-16
CZ282021B6 (cs) 1997-04-16
ZA922776B (en) 1993-10-15
DE69211220D1 (de) 1996-07-11
MX9201946A (es) 1992-11-01
KR920019365A (ko) 1992-11-19
CY1975A (en) 1997-09-05
FI101795B1 (fi) 1998-08-31
TW216399B (cs) 1993-11-21
FI921876A0 (fi) 1992-04-27
ATE144425T1 (de) 1996-11-15
NO180450B (no) 1997-01-13
KR100194307B1 (ko) 1999-06-15
NZ242505A (en) 1993-06-25
FI921877A0 (fi) 1992-04-27
HU9201398D0 (en) 1992-07-28
ZA922777B (en) 1993-10-15
RU2070203C1 (ru) 1996-12-10
ES2093779T3 (es) 1997-01-01
CN1066270A (zh) 1992-11-18
AU1525792A (en) 1992-11-05
CS127692A3 (en) 1992-11-18
AU1525592A (en) 1992-11-05
HU213613B (en) 1997-08-28
IL101705A0 (en) 1992-12-30
EP0511800A1 (en) 1992-11-04
JP3135672B2 (ja) 2001-02-19
ES2088098T3 (es) 1996-08-01
NZ242506A (en) 1993-09-27
BR9201540A (pt) 1992-12-01
GR3021706T3 (en) 1997-02-28
JPH05117154A (ja) 1993-05-14
KR100193742B1 (ko) 1999-06-15

Similar Documents

Publication Publication Date Title
DE69133396D1 (de) Warenauszahlsystem
DE69212332D1 (de) Farbball
DE59206583D1 (de) Windsichter
DE69219551D1 (de) Überrahmen
ATE137279T1 (de) Stoffauflauf
DE59209950D1 (de) Flaschendispenser
DE69219252D1 (de) Ölbehälter
ATA131391A (de) Reibring
BR9204511A (pt) Recolhedor-enrolador
DE59208716D1 (de) Lymphoides cd30-antigen
DE69232880D1 (de) Bittaktrückgewinnungsschaltung
DE69126968D1 (de) Tamburin
DE59207013D1 (de) Sportschuh
FI921876L (fi) Farmaceutisk komposition innehaollande diritromycin
DE69230668D1 (de) Imaginograph
ATA170491A (de) Mauerstein
ATE163916T1 (de) Ethyl-6-formyloxy-4-hexenoat
DE69220547D1 (de) 5-substituierte-2-Oxazolidinone
ATA67791A (de) Rollski
ATA9892A (de) Formstein
CA68725S (fr) Mobilier-jeu
BR7100738U (pt) Aerofolio
BR9100002A (pt) Candress
BR9100957A (pt) Centrografo
BR9101584A (pt) Sofa-beliche

Legal Events

Date Code Title Description
FD Application lapsed